ArticleNature communications2025

Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer.

Binyu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.